Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases
<p>Abstract</p> <p>Recent studies of inherited neurodegenerative disorders have suggested a linkage between the propensity toward aggregation of mutant protein and disease onset. This is particularly apparent for polyglutamine (polyQ) diseases caused by expansion of CAG-trinucleoti...
Main Authors: | Matsubara Shiro, Sugaya Keizo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-07-01
|
Series: | Molecular Neurodegeneration |
Online Access: | http://www.molecularneurodegeneration.com/content/4/1/29 |
Similar Items
-
Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
by: Sugaya Keizo, et al.
Published: (2012-05-01) -
Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
by: Keizo Sugaya, et al.
Published: (2007-01-01) -
Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
by: Eiko N. Minakawa, et al.
Published: (2021-02-01) -
Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
by: Toshihide Takeuchi, et al.
Published: (2017-10-01) -
Molecular origin of polyglutamine aggregation in neurodegenerative diseases.
by: Sagar D Khare, et al.
Published: (2005-08-01)